DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

A Quality Improvement Plan for Hypertension Control

Information source: Jordi Gol i Gurina Foundation
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Hypertension

Intervention: Quality Improvement plan for Hypertension Control (Other)

Phase: N/A

Status: Completed

Sponsored by: Jordi Gol i Gurina Foundation

Official(s) and/or principal investigator(s):
Roser Valles Fernandez, Principal Investigator, Affiliation: Institut Català de la salut


The study hypothesis is that the implementation of a plan for quality improvement at the primary care health teams taking care of hypertensive patients, will increase the level of blood pressure control among those patients.

Clinical Details

Official title: A Quality Improvement Plan for Hypertension Control: the INCOTECA Project

Study design: Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Health Services Research

Primary outcome: good control of hypertension as a dichotomous variable, based on systolic blood pressure and diastolic blood pressure records over the last 12 months

Secondary outcome: treatment with antihypertensive drugs, number of antihypertensive drugs, assessment of therapeutic compliance

Detailed description: The study is to compare the results on the hypertension control between two groups of primary health care teams. The intervention group will undertake a quality improvement plan for hypertension control, in which the following aspects will be included in the intervention: Specific training programme on how to diagnose hypertension , and measure blood pressure correctly To send feed back information to primary care health professionals about poorly controlled hypertensive patients An audit will be performed, every 6 months, to see the adhesion to the recommended clinical guidelines , and the information will be diffused among the participant primary health care professionals Each participant primary health care team will have a designated reference person, that will provide support on any doubts on the programme implementation. The non intervention group will follow hypertensive patients following the same clinical practice guide as the intervention group, with no intervention on the primary health care professionals


Minimum age: 18 Years. Maximum age: N/A. Gender(s): Both.


Inclusion Criteria:

- Patients diagnosed with hypertension before January 1st, 2006

- Patients assigned at the primary health team participating, and with clinical

electronic records Exclusion Criteria:

- Patients diagnosed with hypertension after January 1st, 2006

- Patients under 18 years of age

- Patients with a diastolic blood pressure higher than systolic blood pressure as

recorded in the clinical records

Locations and Contacts

SAP Cerdanyola-Ripollet Institut Català de la Salut, Cerdanyola del Vallès, Barcelona, Spain
Additional Information

describes de procedures to follow management and treatment of hypertensive patients in the study protocol

Starting date: February 2006
Last updated: May 6, 2009

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017